Boston Partners grew its position in shares of The Pennant Group, Inc. (NASDAQ:PNTG – Free Report) by 15.2% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 115,682 shares of the company’s stock after buying an additional 15,291 shares during the quarter. Boston Partners’ holdings in The Pennant Group were worth $2,273,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Allianz Asset Management GmbH bought a new position in The Pennant Group in the 4th quarter valued at $2,351,000. Keeley Teton Advisors LLC purchased a new stake in The Pennant Group during the fourth quarter worth about $603,000. Wasatch Advisors LP raised its position in The Pennant Group by 3.3% in the fourth quarter. Wasatch Advisors LP now owns 1,465,754 shares of the company’s stock worth $20,403,000 after acquiring an additional 46,484 shares during the period. Sei Investments Co. boosted its stake in The Pennant Group by 679.7% in the first quarter. Sei Investments Co. now owns 136,026 shares of the company’s stock valued at $2,670,000 after acquiring an additional 118,581 shares during the last quarter. Finally, 8 Knots Management LLC purchased a new stake in shares of The Pennant Group during the 4th quarter worth approximately $25,578,000. Hedge funds and other institutional investors own 85.88% of the company’s stock.
The Pennant Group Price Performance
Shares of The Pennant Group stock traded down $0.65 on Friday, reaching $29.26. The stock had a trading volume of 201,016 shares, compared to its average volume of 208,326. The business’s 50 day moving average is $24.94 and its two-hundred day moving average is $21.07. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.51. The Pennant Group, Inc. has a 1 year low of $10.31 and a 1 year high of $31.23. The company has a market cap of $879.15 million, a P/E ratio of 54.19, a price-to-earnings-growth ratio of 3.17 and a beta of 2.00.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the company. Truist Financial increased their price target on The Pennant Group from $25.00 to $28.00 and gave the stock a “hold” rating in a research note on Monday, July 15th. Royal Bank of Canada increased their target price on shares of The Pennant Group from $21.00 to $26.00 and gave the stock an “outperform” rating in a research report on Thursday, May 9th. Finally, Stephens reissued an “overweight” rating and issued a $25.00 price target on shares of The Pennant Group in a research report on Thursday, June 20th.
View Our Latest Report on PNTG
About The Pennant Group
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
See Also
- Five stocks we like better than The Pennant Group
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- Which Wall Street Analysts are the Most Accurate?
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Basic Materials Stocks Investing
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Want to see what other hedge funds are holding PNTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Pennant Group, Inc. (NASDAQ:PNTG – Free Report).
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.